Pituitary tumors and tumors of the sellar region
Surgical Neuro-Oncology: In Multiple Choice Questions, Page: 175-184
2024
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Book Chapter Description
This chapter provides a detailed exploration of tumors and tumors of the sellar region. It covers a range of tumor types, including pituitary adenomas, adamantinomatous and papillary craniopharyngiomas, pituicytomas, spindle cell oncocytoma, and pituitary carcinoma. It offers insights into their definition, epidemiology, pathology, molecular genetics, etiology, and clinical presentation. It further addresses staging and classification, diagnostic procedures, and various treatment options and considerations. The critical aspects of recurrence, follow-up, and prognosis are also discussed. This chapter serves to facilitate a well-structured approach to understanding and managing these tumors in the field of surgical neuro-oncology.
Bibliographic Details
http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85205087385&origin=inward; http://dx.doi.org/10.1007/978-3-031-53642-7_13; https://link.springer.com/10.1007/978-3-031-53642-7_13; https://dx.doi.org/10.1007/978-3-031-53642-7_13; https://link.springer.com/chapter/10.1007/978-3-031-53642-7_13
Springer Science and Business Media LLC
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know